Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis

QR Code

Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis

Hydrogen cyanide is readily detected in the headspace above Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis (CF) patients with chronic (P. aeruginosa) infection. We investigated if exhaled breath HCN is an early marker of P. aeruginosa infection. 233 children with CF who were...

Full description

Bibliographic Details
Main Authors:	Gilchrist, Francis J., Belcher, John, Jones, Andrew M., Smith, David, Smyth, Alan R., Southern, Kevin W., Španěl, Patrik, Webb, A. Kevin, Lenney, Warren
Format:	Article
Published:	European Respiratory Society 2015
Online Access:	https://eprints.nottingham.ac.uk/31677/

Similar Items

Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)

Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
by: Barr, Helen L., et al.
Published: (2015)

Lectin-mediated biofilm maturation, quorum sensing and Pseudomonas aeruginosa infections in cystic fibrosis
by: Crusz, S.A.
Published: (2009)

Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans
by: Costello, A., et al.
Published: (2014)

Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study
by: Palser, Sally C., et al.
Published: (2016)

Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report
by: Subbarao, P., et al.
Published: (2015)

HOST DEFENCE PEPTIDE AS AN INNOVATIVE NOVEL THERAPY FOR PSEUDOMONAS AERUGINOSA BIOFILM INFECTIONS IN THE CYSTIC FIBROSIS LUNG
by: Wannigama, D., et al.
Published: (2019)

Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa
by: Spencer, Daniella Lucy
Published: (2019)

Research Protocol - Effect of anti-staphylococcal antibiotic prophylaxis upon isolation and colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and their resistant variants in cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2016)

Multiple-breath washout outcomes are sensitive to inflammation and infection in children with cystic fibrosis
by: Ramsey, K., et al.
Published: (2017)

Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection
by: Darch, Sophie E., et al.
Published: (2015)

Elucidating and Utilising the Mechanisms Used by Pseudomonas aeruginosa to Develop Resistance to Bacteriophages to Aid Therapeutic Formulation and Application in Cystic Fibrosis
by: Vaitekenas, Andrew
Published: (2023)

Design and simulation of electroacoustic sensor for exhaled breath analysis
by: Hazadi, Ahmad Hafiz Faqruddin, et al.
Published: (2018)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)

Can aerosolised bacteriophage preparations against Pseudomonas aeruginosa protect against endotoxin-mediated inflammation in the lungs of people with cystic fibrosis?
by: Trend, S., et al.
Published: (2016)

Cystic fibrosis microbiology: advances in antimicrobial therapy
by: Waters, Valerie, et al.
Published: (2015)

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

Cystic Fibrosis isolates of Pseudomonas aeruginosa retain iron-regulated antimicrobial activity against Staphylococcus aureus through the action of multiple alkylquinolones
by: Nguyen, Angela T., et al.
Published: (2016)

The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways
by: Trend, S., et al.
Published: (2017)

European Cystic Fibrosis Society standards of care: best practice guidelines
by: Smyth, Alan R., et al.
Published: (2014)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Neutrophil Elastase Activity During Episodes Of Pseudomonas Infection In Early Cystic Fibrosis
by: Garratt, L.W., et al.
Published: (2016)

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: a longitudinal study
by: Barr, Helen L., et al.
Published: (2017)

NEUTROPHIL ELASTASE ACTIVITY IN EARLY CYSTIC FIBROSIS PRIOR TO, DURING AND POST PSEUDOMONAS INFECTION
by: Garratt, L., et al.
Published: (2016)

Exhaled breath temperature in healthy children is influenced by room temperature and lung volume
by: Logie, K., et al.
Published: (2011)

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
by: Smyth, Alan R.
Published: (2015)

Direct and Rapid Electrochemical Detection of Pseudomonas aeruginosa Quorum Signaling Molecules in Bacterial Cultures and Cystic Fibrosis Sputum Samples through Cationic Surfactant-Assisted Membrane Disruption
by: Buzid, A., et al.
Published: (2017)

Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma
by: Romieu, I., et al.
Published: (2008)

Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

The clinical utility of lung clearance index in early cystic fibrosis lung disease is not impacted by the number of multiple-breath washout trials
by: Foong, Rachel, et al.
Published: (2018)

Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)

Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
by: Smyth, Alan R., et al.
Published: (2014)

Riboregulation in Pseudomonas aeruginosa
by: Silistre, Hazel
Published: (2016)

Free neutrophil elastase activity in airways of young children with cystic fibrosis prior to, during and post-Pseudomonas infection
by: Garratt, L., et al.
Published: (2016)

Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)